Msida

Msida has emerged as a premier Mediterranean hub for the life sciences ecosystem, strategically integrating academic excellence with industrial innovation.

At the heart of this cluster is the Malta Life Sciences Park (MLSP), which provides over 13,500 square meters of state-of-the-art laboratory facilities and co-working spaces for biotechnology startups and established firms.

The region is best known for its robust pharmaceutical sector, benefiting from Malta’s unique Bolar-type patent exemptions that accelerate the development of generic medicines.

Adjacently, the University of Malta drives academic research in molecular medicine, genetics and bioinformatics, fostering a high-caliber talent pool for global markets.

Healthcare innovation is further bolstered by the proximity of Mater Dei Hospital, the island’s primary teaching hospital, which facilitates translational research and clinical trials.

Msida’s growing medical device industry focuses on precision engineering and digital health solutions, including wearable technologies and health IT.

International partners are drawn to the region's EU-compliant regulatory framework and strategic access to Middle Eastern and African markets.

By bridging the gap between healthcare providers and private enterprise, Msida continues to solidify its reputation as a center for biomedical excellence and R&D investment.